(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Revlon New, Safeguard Scientifics New, and Zai Lab.

Rank Financial Asset Price Change Updated (EST)
1 Revlon New (REV) 6.06 62.47% 2022-06-22 01:08:05
2 Safeguard Scientifics New (SFE) 4.13 15.04% 2022-06-22 05:15:14
3 Zai Lab (ZLAB) 32.71 12.6% 2022-06-22 14:55:23
4 Novavax (NVAX) 45.47 9.92% 2022-06-22 14:58:32
5 Castle Biosciences (CSTL) 17.75 8.2% 2022-06-22 14:48:14
6 Inovio Pharmaceuticals (INO) 1.86 8.14% 2022-06-22 14:59:04
7 Sorrento Therapeutics (SRNE) 2.25 7.93% 2022-06-22 14:46:14
8 Panhandle Oil and Gas (PHX) 3.69 7.58% 2022-06-21 19:42:13
9 Shaw Communications (SJR) 28.57 7.29% 2022-06-22 07:12:05
10 Upwork (UPWK) 20.43 6.74% 2022-06-22 14:50:49

The three most active and biggest losers today are Riot Blockchain, Kosmos Energy, and Altria Group.

Rank Financial Asset Price Change Updated (EST)
1 Riot Blockchain (RIOT) 4.56 -10.51% 2022-06-22 14:50:05
2 Kosmos Energy (KOS) 6.18 -9.04% 2022-06-22 14:59:54
3 Altria Group (MO) 41.58 -9% 2022-06-22 14:46:48
4 Arcelor Mittal (MT) 23.72 -8.45% 2022-06-22 14:56:40
5 Coinbase (COIN) 52.64 -8.44% 2022-06-22 14:53:24
6 Freeport (FCX) 31.30 -8.02% 2022-06-22 14:59:32
7 Pennsylvania Real Estate Investment Trust (PEI) 3.90 -7.8% 2022-06-21 19:06:11
8 Gevo (GEVO) 2.51 -7.56% 2022-06-22 14:43:01
9 Roadrunner Transportation Systems (RRTS) 2.83 -7.21% 2022-06-22 03:12:06
10 Marathon Oil (MRO) 23.14 -7.05% 2022-06-22 14:46:55

Most Active Winners today

1. Revlon New (REV) – 62.47%

Through its subsidiaries, Revlon, Inc. develops, produces, markets, distributes, sells, and supports beauty and personal care products around the world. Relvon, the company’s color cosmetics segment, offers beauty products under Revlon brands. Revlon ColorSilk is the Revlon Professional brand for hair color. The Elizabeth Arden segment sells, markets and distributes skin care products for Elizabeth Arden Ceramide and Prevage brands. It also has fragrances that are under Elizabeth Arden White Tea and Elizabeth Arden Red Door brands. Its Portfolio segment includes color cosmetics from the SinfulColors and Almay brands, men’s grooming products for the American Crew brand, nail polishes and gel nails under CND brand, anti-perspirant products under Mitchum brand, hair care products under Creme of Nature, and a hair color range under Llongueras. The Fragrances segment markets and distributes licensed and owned fragrances as well as prestige brands that are owned or licensed by the company. The Juicy Couture and AllSaints brand names are available. The company’s products are sold through its sales team, independent distributors and sales reps. It also licenses the Revlon and The Elizabeth Arden trademarks to manufacturers of accessories and complementary products. Revlon, Inc., was established in New York, New York, in 1932.

NYSE ended the session with Revlon New rising 62.47% to $6.06 on Wednesday while NYSE slid 0.43% to $14,352.78.

Volume

Today’s last reported volume for Revlon New is 181962000 which is 1909.48% above its average volume of 9055200.

Revlon New’s last close was $6.06, 65.67% below its 52-week high of $17.65.

The company’s growth estimates for the current quarter is a negative 4.8% and positive 8.2% for the next.

Revlon New’s Revenue

Year-on-year quarterly revenue growth grew by 7.8%, now sitting on 2.11B for the twelve trailing months.

Revlon New’s Stock Yearly Top and Bottom Value

Revlon New’s stock is valued at $6.06 at 17:32 EST, way below its 52-week high of $17.65 and way higher than its 52-week low of $1.08.

Revlon New’s Moving Average

Revlon New’s value is way higher than its 50-day moving average of $5.08 and way below its 200-day moving average of $9.17.

More news about Revlon New.

2. Safeguard Scientifics New (SFE) – 15.04%

Safeguard Scientifics, Inc. is no longer interested in investing. This venture capital and private equity firm is focused on expansion financings and growth capital. The firm invests initially in Series A-C rounds and then opportunistically, in seed rounds. It prefers to invest in technology and financial services companies. It invests in technology sectors such as software-as-a-service, adtech/digital media, Internet of Everything and enhanced security. The firm also invests in the healthcare sector. It is involved with molecular, point-of-care and regenerative medicine. Medical technology, digital healthcare, special pharmaceuticals and other healthcare-related services. The firm invests in the United States, with a particular focus on the Mid-Atlantic and Southeastern Canada. It invests in between $5 and $25 millions in growth equity financing, and $5 to $10 million in early stage financing. The firm invests in capital structures, including venture capital-backed growth partners, owner-financed, bootstrapped businesses, or corporate divisions. It prefers to own the majority of its portfolio companies with ownership ranging from 20 to 50%. It may, however, take a smaller or majority stake in portfolio companies. The firm prefers to invest only in businesses with intellectual property and proprietary technology. It prefers to be a member of the Board in portfolio companies. In 1953, the company was originally called Lancaster Corporation. It changed its name in 1981 to Safeguard Scientifics, Inc. Safeguard Scientifics, Inc. has an office in Weston, Massachusetts and is located in Radnor, Pennsylvania.

NYSE ended the session with Safeguard Scientifics New rising 15.04% to $4.13 on Wednesday, after three consecutive sessions in a row of gains. NYSE slid 0.43% to $14,352.78, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Safeguard Scientifics New is 41666 which is 43.01% above its average volume of 29133.

Safeguard Scientifics New’s last close was $4.13, 54.01% below its 52-week high of $8.98.

Safeguard Scientifics New’s Stock Yearly Top and Bottom Value

Safeguard Scientifics New’s stock is valued at $4.13 at 17:32 EST, way below its 52-week high of $8.98 and way above its 52-week low of $3.32.

Safeguard Scientifics New’s Moving Average

Safeguard Scientifics New’s value is higher than its 50-day moving average of $4.12 and way under its 200-day moving average of $6.35.

More news about Safeguard Scientifics New.

3. Zai Lab (ZLAB) – 12.6%

Zai Lab Limited is a biopharmaceutical firm that focuses on developing and licensing therapeutics for medical use in China. Niraparib is an oral small-molecule poly ADPribose Polymerase 1/2 inhibitor that can be used to treat multiple solid tumors such as ovarian or other forms of lung cancer. Optune is a treatment for glioblastoma multiforme. Ripretinib is a switch inhibitor that can be used to treat KIT- and/or PDGFRa driven cancers. It also produces REGN1979, which treats diffuse large B cell lymphoma, and follicular Lymphoma. Margetuximab is an immuno-optimized monoclonal anti-HER2 antibody. INCMGA0012, an investigatoral monoclonal antibodies, for treatment MSI-high endometrial carcinoma. Bemarituzumab is a monoclonal humanized antibody that can be used to treat gastric or gastroesophageal carcinomas. Omadacycline and Durlobactam are antibiotics for treating acinetobacter and baumannii bacteria infections. Zai Lab Limited is a licensee and has a collaboration agreement with Paratek Bermuda, Ltd., TESARO Inc., Entasis Therapeutics Holdings, Inc., Crescendo Biologics Ltd., Novocure Limited, MacroGenics Inc., Deciphera Pharmaceuticals, LLC, and Incyte Corporation. China’s Shanghai is the headquarters of this company, which was established in 2013.

NASDAQ ended the session with Zai Lab rising 12.6% to $32.71 on Wednesday, after two successive sessions in a row of gains. NASDAQ dropped 0.15% to $11,053.08, after two successive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Zai Lab is 1094710 which is 71.18% above its average volume of 639501.

Zai Lab’s last close was $29.05, 83.76% below its 52-week high of $178.91.

Zai Lab’s Sales

Zai Lab’s sales growth is 54.1% for the ongoing quarter and 55.7% for the next. The company’s growth estimates for the present quarter and the next is 65.5% and 39.2%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zai Lab’s stock is considered to be oversold (<=20).

Zai Lab’s Stock Yearly Top and Bottom Value

Zai Lab’s stock is valued at $32.71 at 17:32 EST, way below its 52-week high of $178.91 and way above its 52-week low of $22.51.

Zai Lab’s Moving Average

Zai Lab’s value is under its 50-day moving average of $34.58 and way under its 200-day moving average of $64.47.

More news about Zai Lab.

4. Novavax (NVAX) – 9.92%

Novavax, Inc., along with Novavax AB, a subsidiary, focuses on developing, commercializing and marketing vaccines that prevent serious infections. ResVax is a candidate for a vaccine against respiratory syncytial viruses (RSV), fusion (F). The Phase III clinical trials are underway to test the vaccine in infants. NanoFlu is a Phase III clinical study that treats seasonal influenza in elderly adults. Matrix-M is the company’s main adjuvant. It is used to increase the immune system attack against microorganisms and to immunize with lower levels of antigen. RSV F vaccine is being developed by the company for elderly (60+) and healthy children (6 months to 5 years old). Phase I clinical trials are underway. It is also developing nanoparticle vaccine candidates to be used in clinic testing for the ebola virus. The company also has a COVID-19 vaccine being developed for the coronavirus, which causes symptoms similar to pneumonia. This is currently in preclinical phase. Novavax, Inc., was established in 1987. It is located in Gaithersburg, Maryland.

NASDAQ ended the session with Novavax rising 9.92% to $45.47 on Wednesday, after two successive sessions in a row of gains. NASDAQ dropped 0.15% to $11,053.08, after two sequential sessions in a row of gains, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Novavax is 6354460 which is 8.05% above its average volume of 5880920.

Novavax’s last close was $41.37, 85.11% under its 52-week high of $277.80.

The company’s growth estimates for the current quarter and the next is 210.7% and 254.1%, respectively.

Novavax’s Revenue

Year-on-year quarterly revenue growth declined by 20.5%, now sitting on 1.15B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Novavax’s stock is considered to be oversold (<=20).

Novavax’s Stock Yearly Top and Bottom Value

Novavax’s stock is valued at $45.47 at 17:32 EST, way under its 52-week high of $277.80 and way higher than its 52-week low of $34.88.

Novavax’s Moving Average

Novavax’s value is way under its 50-day moving average of $50.63 and way under its 200-day moving average of $120.50.

More news about Novavax.

5. Castle Biosciences (CSTL) – 8.2%

Castle Biosciences, Inc., which is a company that develops and markets diagnostic and prognostic tools for skin cancers, has reached commercial stage. DecisionDx–Melanoma is the company’s flagship product. This multi-gene expression profil (GEP test) identifies stage I/I patients who are at highest risk for metastasis using biological information from 31 tumor tissues. DecisionDx-UM is a GEP proprietary test which predicts metastasis risk for patients suffering from uveal melanoma. There are also two proprietary products at late stage that address cutaneous squamous cells carcinoma and suspicious pigmented lesion, both indications of high clinical need in dermatological. The company offers testing services via physicians, nurse practitioners, physician assistants and physician assistants. It was established in Texas in 2007.

NASDAQ ended the session with Castle Biosciences rising 8.2% to $17.75 on Wednesday while NASDAQ dropped 0.15% to $11,053.08.

Volume

Today’s last reported volume for Castle Biosciences is 194577 which is 50.13% below its average volume of 390170.

Castle Biosciences’s last close was $16.41, 79.21% below its 52-week high of $78.92.

The company’s growth estimates for the ongoing quarter and the next is a negative 114.3% and a negative 68.1%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Castle Biosciences’s stock is considered to be oversold (<=20).

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $17.75 at 17:32 EST, way below its 52-week high of $78.92 and higher than its 52-week low of $17.01.

Castle Biosciences’s Moving Average

Castle Biosciences’s value is way under its 50-day moving average of $24.61 and way under its 200-day moving average of $44.68.

More news about Castle Biosciences.

6. Inovio Pharmaceuticals (INO) – 8.14%

Inovio Pharmaceuticals, Inc. is a biotech company that focuses on developing, commercializing, and marketing DNA medicines. These DNA medicines are used to cure, protect, and treat diseases such as cancer, human papillomavirus, and other infectious diseases. The SynCon immunotherapy design of Inovio Pharmaceuticals, Inc. can break the immune system’s tolerance for cancerous cells. It also facilitates cross-strain protection from unmatched or matched pathogens. It is currently involved in planning and conducting clinical trials of DNA medicines to treat HPV-associated diseases, including anal and cervical vulvar dysplasia, HPV-associated cervical cancers and other HPV related disorders such as Ebola, Middle East Respiratory syndrome (MERS), Lassa virus, Zika virus, COVID-19 virus, and coronavirus. ApolloBio Corp. or AstraZeneca PLC, Beijing Advaccine Biotechnology Co. and The Bill & Melinda Gates Foundation are its partners and collaborators. To support the investigational DNA vaccine, INO-4800 is being tested in Phase 1 clinical trials for COVID-19. The company has also signed an agreement with Richter-Helm BioLogics GmbH & Co. KG. Plymouth Meeting is the headquarters of this company, which was established in 1979.

NASDAQ ended the session with Inovio Pharmaceuticals rising 8.14% to $1.86 on Wednesday while NASDAQ fell 0.15% to $11,053.08.

Volume

Today’s last reported volume for Inovio Pharmaceuticals is 7549690 which is 25.79% above its average volume of 6001380.

Inovio Pharmaceuticals’s last close was $1.72, 82.73% below its 52-week high of $9.96.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is 138.1% for the ongoing quarter and a decline by 33% for the next. The company’s growth estimates for the present quarter is 17.9% and a drop 3.4% for the next.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 85%, now sitting on 1.77M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Inovio Pharmaceuticals’s stock is considered to be oversold (<=20).

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $1.86 at 17:32 EST, way below its 52-week high of $9.96 and way above its 52-week low of $1.38.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s value is way below its 50-day moving average of $2.31 and way below its 200-day moving average of $4.74.

More news about Inovio Pharmaceuticals.

7. Sorrento Therapeutics (SRNE) – 7.93%

Sorrento Therapeutics, Inc., is a biopharma company at clinical stage. It develops treatments for neurodegenerative, autoimmune, and cancer. The company operates in two segments: Sorrento Therapeutics, and Scilex. It offers cancer therapies by using its G-MAB proprietary antibody library and targeted delivery modes. These include CAR-T, dimeric antigen T-cell treatment (CAR-T), and antibody drug conjugates as well as bispecific approaches. Sofusa is a technology to deliver biologics directly to the lymphatic system. The company is also developing anti-CD38 CAR–T therapies for multiple myeloma and amyloidosis. It also develops resiniferatoxin (a non-opioid TRPV1 antagonist neurotoxin) for treatment of osteoarthritis and late-stage cancer; ZTlido (a lidocaine delivery method for postherpetic nerve pain); and ZTicro, which is a novel, opioid-free, TRPV1-based TRPV1-agonist neurotoxin. SEMDEXA is an injectable viscous jelly formulation that the company has been developing. It’s currently in Phase III clinical trials for sciatica. SP-103 is an investigational, non-aqueous, lidocaine-based topical system in chronic low-back pain. SmartPharm Therapeutics Inc. is one of its partners in developing a gene-encoded vaccine against COVID-19. Celularity, Inc. initiated Phase I/II clinical studies, which included up to 86 patients. Mount Sinai Health System was involved in the development of COVI-SHIELD, an anti-SARS treatment. It also has a preclinical agreement with Galveston’s University of Texas Medical Branch for testing Sorrento’s COVID-19 therapeutic products candidates. It was established in San Diego in 2006.

NASDAQ ended the session with Sorrento Therapeutics jumping 7.93% to $2.25 on Wednesday, after two consecutive sessions in a row of gains. NASDAQ slid 0.15% to $11,053.08, after two successive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Sorrento Therapeutics is 29026500 which is 214.38% above its average volume of 9232820.

Sorrento Therapeutics’s last close was $2.08, 81.21% below its 52-week high of $11.07.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is 29% for the ongoing quarter and 85.1% for the next. The company’s growth estimates for the present quarter is a negative 1700% and positive 77.2% for the next.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 13.7%, now sitting on 52.9M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sorrento Therapeutics’s stock is considered to be oversold (<=20).

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $2.25 at 17:32 EST, way under its 52-week high of $11.07 and way higher than its 52-week low of $1.15.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s value is way above its 50-day moving average of $1.70 and way under its 200-day moving average of $4.40.

More news about Sorrento Therapeutics.

8. Panhandle Oil and Gas (PHX) – 7.58%

PHX Minerals Incorporated acquires and develops natural gas properties and then manages them in the United States. It produces natural gas and crude oil as well as natural gas liquids. The company’s main properties are in Oklahoma, Arkansas and Texas. The company had 252,443 net minerals in perpetual ownership; it leased 17,091 acres and owned working rights and royalty interests in 6,510 natural gas and oil wells. There were also 125 wells that are in process or being completed. The company sells products to many purchasers including pipeline companies and marketing firms. The former name of the company was Panhandle Oil and Gas Inc., but it changed its name in October 2020 to PHX Minerals Inc. PHX Minerals Inc. is a Oklahoma City-based company that was established in 1926.

NYSE ended the session with Panhandle Oil and Gas rising 7.58% to $3.69 on Wednesday, following the last session’s upward trend. NYSE slid 0.43% to $14,352.78, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Panhandle Oil and Gas is 426538 which is 1.79% above its average volume of 419004.

Panhandle Oil and Gas’s last close was $3.69, 25.9% under its 52-week high of $4.98.

The company’s growth estimates for the present quarter and the next is 320% and 208.3%, respectively.

Panhandle Oil and Gas’s Revenue

Year-on-year quarterly revenue growth grew by 112.8%, now sitting on 43.17M for the twelve trailing months.

Panhandle Oil and Gas’s Stock Yearly Top and Bottom Value

Panhandle Oil and Gas’s stock is valued at $3.69 at 17:32 EST, way below its 52-week high of $4.98 and way higher than its 52-week low of $2.07.

Panhandle Oil and Gas’s Moving Average

Panhandle Oil and Gas’s value is above its 50-day moving average of $3.60 and way higher than its 200-day moving average of $2.93.

More news about Panhandle Oil and Gas.

9. Shaw Communications (SJR) – 7.29%

Shaw Communications Inc. is a North American connectivity company. It operates via the Wireline and Wireless segments. The Wireline Segment provides cable telecommunications services including video, Internet and WiFi as well as phone and satellite video. It also offers data networking via a national fiber-optic backbone network for Canadian customers, North American businesses and public sector entities. Wireless provides voice and data wireless communications services to customers in Ontario and British Columbia through Freedom Mobile and Alberta via Shaw Mobile. Shaw Cablesystems Ltd. was the company’s previous name. Shaw Communications Inc. took over its operations in May 1993. Shaw Communications Inc. was established in 1966. It is located in Calgary, Canada.

NYSE ended the session with Shaw Communications rising 7.29% to $28.57 on Wednesday while NYSE slid 0.43% to $14,352.78.

Volume

Today’s last reported volume for Shaw Communications is 547309 which is 3.62% above its average volume of 528146.

Shaw Communications’s last close was $28.57, 9.59% under its 52-week high of $31.60.

Shaw Communications’s Revenue

Year-on-year quarterly revenue growth declined by 2%, now sitting on 5.5B for the twelve trailing months.

Shaw Communications’s Stock Yearly Top and Bottom Value

Shaw Communications’s stock is valued at $28.57 at 17:32 EST, below its 52-week high of $31.60 and way above its 52-week low of $25.63.

Shaw Communications’s Moving Average

Shaw Communications’s worth is below its 50-day moving average of $28.66 and under its 200-day moving average of $29.35.

More news about Shaw Communications.

10. Upwork (UPWK) – 6.74%

Upwork Inc. is an online talent platform that allows businesses to connect with independent freelancers and agencies in America, India and the Philippines. Upwork Inc.’s platform allows access to approximately 8,000 talents in approximately 70 areas, such as content marketing, customer services, data science, analytics, graphic design and mobile development. It also offers sales and web development. The platform allows clients to automate their workflows such as contracting, talent sourcing and outreach. Its platform provides access to many functions for remote collaboration with freelancers, including communication and collaboration as well as time tracking and invoicing. The marketplace offers include Upwork Basic and Plus, Upwork Business and Enterprise, Upwork Payroll and managed and online escrow services. In May 2015, the company, formerly Elance-oDesk, Inc., changed its name from Upwork Inc. Upwork Inc. was founded in 2013. It is located in Santa Clara California.

NASDAQ ended the session with Upwork rising 6.74% to $20.43 on Wednesday while NASDAQ slid 0.15% to $11,053.08.

Volume

Today’s last reported volume for Upwork is 1181370 which is 5.43% below its average volume of 1249230.

Upwork’s last close was $19.14, 70.32% under its 52-week high of $64.49.

Upwork’s Sales

Upwork’s sales growth is 30.9% for the present quarter and 21.8% for the next. The company’s growth estimates for the ongoing quarter is 200% and a drop 300% for the next.

Upwork’s Revenue

Year-on-year quarterly revenue growth grew by 32.4%, now sitting on 472.09M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Upwork’s stock is considered to be oversold (<=20).

Upwork’s Stock Yearly Top and Bottom Value

Upwork’s stock is valued at $20.43 at 17:32 EST, way under its 52-week low of $33.11.

Upwork’s Moving Average

Upwork’s value is way under its 50-day moving average of $46.90 and way under its 200-day moving average of $47.44.

More news about Upwork.

Most Active Losers Today

1. Riot Blockchain (RIOT) – -10.51%

NASDAQ ended the session with Riot Blockchain falling 10.51% to $4.56 on Wednesday, after four successive sessions in a row of gains. NASDAQ slid 0.15% to $11,053.08, after two consecutive sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Riot Blockchain is 12790000 which is 18.36% above its average volume of 10805400.

Riot Blockchain’s last close was $5.09, 89% below its 52-week high of $46.28.

Riot Blockchain’s Sales

Riot Blockchain’s sales growth is 1759.8% for the present quarter and 411.3% for the next. The company’s growth estimates for the present quarter and the next is 212.5% and 444.4%, respectively.

Riot Blockchain’s Revenue

Year-on-year quarterly revenue growth grew by 2532.3%, now sitting on 127.64M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Riot Blockchain’s stock is considered to be oversold (<=20).

Riot Blockchain’s Stock Yearly Top and Bottom Value

Riot Blockchain’s stock is valued at $4.56 at 17:32 EST, way under its 52-week low of $6.25.

Riot Blockchain’s Moving Average

Riot Blockchain’s value is way below its 50-day moving average of $15.16 and way under its 200-day moving average of $24.25.

More news about Riot Blockchain.

2. Kosmos Energy (KOS) – -9.04%

Kosmos Energy Ltd. is a independent deepwater oil and gas exploration company that focuses on the Atlantic Margins. Its main assets are production off Ghana and Equatorial Guinea and the U.S. Gulf of Mexico. There is also a gas development project offshore Mauritania, Senegal, and offshore Mauritania. The company also has an exploration program that balances between infrastructure-led, frontier, and proven basin exploration. Dallas is the headquarters of this company, which was established in 2003.

NYSE ended the session with Kosmos Energy dropping 9.04% to $6.18 on Wednesday, following the last session’s upward trend. NYSE slid 0.43% to $14,352.78, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Kosmos Energy is 10173000 which is 7.59% below its average volume of 11009300.

Kosmos Energy’s last close was $6.80, 19.91% below its 52-week high of $8.49.

Kosmos Energy’s Revenue

Year-on-year quarterly revenue growth grew by 108.9%, now sitting on 1.33B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Kosmos Energy’s stock is considered to be overbought (>=80).

Kosmos Energy’s Stock Yearly Top and Bottom Value

Kosmos Energy’s stock is valued at $6.18 at 17:32 EST, way below its 52-week high of $8.49 and way above its 52-week low of $1.80.

Kosmos Energy’s Moving Average

Kosmos Energy’s value is way under its 50-day moving average of $7.30 and way above its 200-day moving average of $4.96.

More news about Kosmos Energy.

3. Altria Group (MO) – -9%

Altria Group, Inc., via its subsidiaries, produces and sells cigarettes, wine, and smokeless products in the United States. The company offers cigarettes primarily under Marlboro’s brand, cigars mainly under Black & Mild, as well moist, smokeless tobacco products under Skoal and Red Seal brands. oral nicotine pouches. Chateau Ste also makes and sells table and varietal wines. Michelle, 14 Hands; the company owns Stag’s Leap Wine Cellars (Conn Creek, Patz & Hall), and Erath wine labels. It also imports and markets Champagne Nicolas Feuillatte wines in the United States. It also provides financing leasing services, primarily for the transportation, power generation and real estate industries. It sells tobacco products to large retailers, chain stores, wholesalers and distributors. Altria Group, Inc., was established in 1822. It is located in Richmond, Virginia.

NYSE ended the session with Altria Group dropping 9% to $41.58 on Wednesday, following the last session’s upward trend. NYSE slid 0.43% to $14,352.78, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for Altria Group is 36710100 which is 237.05% above its average volume of 10891300.

Altria Group’s last close was $45.70, 19.89% under its 52-week high of $57.05.

The company’s growth estimates for the present quarter and the next is 1.6% and 8.2%, respectively.

Altria Group’s Revenue

Year-on-year quarterly revenue growth declined by 1.3%, now sitting on 21.05B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Altria Group’s stock is considered to be overbought (>=80).

Altria Group’s Stock Yearly Top and Bottom Value

Altria Group’s stock is valued at $41.58 at 17:32 EST, under its 52-week low of $42.53.

Altria Group’s Moving Average

Altria Group’s value is way below its 50-day moving average of $53.11 and way below its 200-day moving average of $49.71.

More news about Altria Group.

4. Arcelor Mittal (MT) – -8.45%

ArcelorMittal and its subsidiaries own and operate steel mining and manufacturing facilities across Europe, North America, Asia and Africa. Semi-finished flat products such as slabs are the company’s main products. They also produce finished flat products such as plates, hot and cold-rolled coils or sheets, hot–dipped and electro-galvanized sheets and hot-dipped coils. Tinplate and color-coated coils as well as tinplates and sheet sheets. The finished products that include bars, wire rods, sections, rails. sheets piles and wire-products as well as seamless and welded tubes and pipes. The company’s main mining products include iron ore lumps and fines as well as concentrates and pellets. Through a central marketing agency and distributors, the company sells products to various industries such as engineering, technology, manufacturing, energy and machine. The company has iron ore mines in Brazil, Canada, Mexico, Liberia and Ukraine; as well as coal mining operations in Kazakhstan and the United States. Luxembourg City is the headquarters of this company, which was established in 1976.

NYSE ended the session with Arcelor Mittal dropping 8.45% to $23.72 on Wednesday while NYSE fell 0.43% to $14,352.78.

Volume

Today’s last reported volume for Arcelor Mittal is 7264850 which is 83.06% above its average volume of 3968490.

Arcelor Mittal’s last close was $25.91, 29.17% below its 52-week high of $36.58.

Arcelor Mittal’s Sales

Arcelor Mittal’s sales growth is 64.7% for the current quarter and 47.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 2536.8% and 1826.3%, respectively.

Arcelor Mittal’s Revenue

Year-on-year quarterly revenue growth grew by 76.2%, now sitting on 62.99B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcelor Mittal’s stock is considered to be overbought (>=80).

Arcelor Mittal’s Stock Yearly Top and Bottom Value

Arcelor Mittal’s stock is valued at $23.72 at 17:33 EST, way under its 52-week high of $36.58 and way above its 52-week low of $20.50.

Arcelor Mittal’s Moving Average

Arcelor Mittal’s value is way under its 50-day moving average of $30.75 and way below its 200-day moving average of $30.93.

More news about Arcelor Mittal.

5. Coinbase (COIN) – -8.44%

NASDAQ ended the session with Coinbase dropping 8.44% to $52.64 on Wednesday, after four consecutive sessions in a row of gains. NASDAQ fell 0.15% to $11,053.08, after two consecutive sessions in a row of gains, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Coinbase is 16834700 which is 47.25% above its average volume of 11432200.

Coinbase’s last close was $57.49, 84.42% under its 52-week high of $368.90.

The company’s growth estimates for the present quarter and the next is a negative 97.7% and a negative 101.2%, respectively.

Coinbase’s Revenue

Year-on-year quarterly revenue growth grew by 327.1%, now sitting on 7.84B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Coinbase’s stock is considered to be oversold (<=20).

Coinbase’s Stock Yearly Top and Bottom Value

Coinbase’s stock is valued at $52.64 at 17:33 EST, way below its 52-week high of $368.90 and way above its 52-week low of $40.83.

Coinbase’s Moving Average

Coinbase’s value is way under its 50-day moving average of $107.90 and way under its 200-day moving average of $210.61.

More news about Coinbase.

6. Freeport (FCX) – -8.02%

NYSE ended the session with Freeport dropping 8.02% to $31.30 on Wednesday, following the last session’s upward trend. NYSE fell 0.43% to $14,352.78, following the last session’s upward trend on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Freeport is 28704200 which is 64.01% above its average volume of 17500500.

Freeport’s last close was $34.03, 34.55% under its 52-week high of $51.99.

The company’s growth estimates for the current quarter and the next is 27.3% and 9%, respectively.

Freeport’s Revenue

Year-on-year quarterly revenue growth grew by 36.1%, now sitting on 24.6B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Freeport’s stock is considered to be overbought (>=80).

Freeport’s Stock Yearly Top and Bottom Value

Freeport’s stock is valued at $31.30 at 17:33 EST, way below its 52-week high of $51.99 and above its 52-week low of $30.02.

Freeport’s Moving Average

Freeport’s value is way below its 50-day moving average of $40.71 and way under its 200-day moving average of $40.45.

More news about Freeport.

7. Pennsylvania Real Estate Investment Trust (PEI) – -7.8%

PREIT (NYSE.PEI) is an publicly traded real-estate investment trust. It owns and manages high quality properties in attractive markets. The robust PREIT portfolio includes carefully selected retail and lifestyle products, as well as destination dining and entertainment experiences. It is primarily located in densely populated areas of the eastern U.S.A. and the top MSAs in the mid-Atlantic. The Company’s transformation has been driven by a focus on quality portfolios and strong balance sheets, supported by disciplined capital spending.

NYSE ended the session with Pennsylvania Real Estate Investment Trust falling 7.8% to $3.90 on Wednesday while NYSE fell 0.43% to $14,352.78.

Volume

Today’s last reported volume for Pennsylvania Real Estate Investment Trust is 202003 which is 160.35% above its average volume of 77589.

Pennsylvania Real Estate Investment Trust’s last close was $3.90, 90.68% under its 52-week high of $41.85.

Pennsylvania Real Estate Investment Trust’s Revenue

Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 299.92M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pennsylvania Real Estate Investment Trust’s stock is considered to be overbought (>=80).

Pennsylvania Real Estate Investment Trust’s Stock Yearly Top and Bottom Value

Pennsylvania Real Estate Investment Trust’s stock is valued at $3.90 at 17:33 EST, way under its 52-week high of $41.85 and above its 52-week low of $3.85.

Pennsylvania Real Estate Investment Trust’s Moving Average

Pennsylvania Real Estate Investment Trust’s value is way below its 50-day moving average of $6.83 and way under its 200-day moving average of $15.84.

More news about Pennsylvania Real Estate Investment Trust.

8. Gevo (GEVO) – -7.56%

Gevo, Inc. is a company that produces renewable fuels. The company sells jet fuel and gasoline to reduce carbon emissions and greenhouse gases. The company uses low-carbon renewable-resource-based carbohydrates as raw materials and is developing renewable electricity and renewable natural gas for use in production processes. The company’s products include isooctane and isobutanol as well as sustainable aviation fuel, isobutylene and ethanol. The former name of the company was Methanotech, Inc., but it changed its name in March 2006 to Gevo, Inc. Gevo, Inc. was established in 2005. It is located in Englewood, Colorado.

NASDAQ ended the session with Gevo sliding 7.56% to $2.51 on Wednesday while NASDAQ dropped 0.15% to $11,053.08.

Volume

Today’s last reported volume for Gevo is 10929900 which is 3.59% above its average volume of 10551100.

Gevo’s last close was $2.71, 67.97% under its 52-week high of $8.46.

Gevo’s Sales

Gevo’s sales growth is a negative 5.2% for the present quarter and 422.2% for the next.

Gevo’s Revenue

Year-on-year quarterly revenue growth declined by 89.8%, now sitting on 711k for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Gevo’s stock is considered to be oversold (<=20).

Gevo’s Stock Yearly Top and Bottom Value

Gevo’s stock is valued at $2.51 at 17:33 EST, way under its 52-week high of $8.46 and higher than its 52-week low of $2.40.

Gevo’s Moving Average

Gevo’s value is way under its 50-day moving average of $3.74 and way below its 200-day moving average of $4.84.

More news about Gevo.

9. Roadrunner Transportation Systems (RRTS) – -7.21%

Roadrunner Transportation Systems, Inc. offers asset-right transport and asset-light logistic services. The company operates in four divisions: Ascent Transportation Management, Ascent On Demand (Ascent OD), Truckload (TL), and Less-thanTruckload. It offers freight audit/payment and asset-backed truckload brokerage. The company also offers ground and air expedite services to transport automotive, industrial, paper, and steel parts. In addition, the company arranges the pickup and delivery of TL freight through its 30 TL service centers in the United States; offers dry van truckload, temperature-controlled truckload, and logistics and warehouse services; and provides pickup, consolidation, linehaul, deconsolidation, and delivery of LTL shipments in the United States and Canada through 27 LTL service centers and approximately 140 third-party delivery agents. The company also offers international ocean and air freight forwarding, customs broker, regulatory compliance and project management. The company operates via a network that includes independent brokers agents, company brokers and direct sales personnel. It offers services under both the Roadrunner and Ascent Global Logistics brand names. Roadrunner Transportation Systems, Inc. is an Illinois company that was founded in 2005. Its headquarters are in Downers Grove, Illinois.

NYSE ended the session with Roadrunner Transportation Systems falling 7.21% to $2.83 on Wednesday while NYSE dropped 0.43% to $14,352.78.

Volume

Today’s last reported volume for Roadrunner Transportation Systems is 376 which is 82.4% below its average volume of 2137.

Roadrunner Transportation Systems’s last close was $2.83, 47.79% under its 52-week high of $5.42.

Roadrunner Transportation Systems’s Revenue

Year-on-year quarterly revenue growth declined by 27.3%, now sitting on 1.85B for the twelve trailing months.

Roadrunner Transportation Systems’s Stock Yearly Top and Bottom Value

Roadrunner Transportation Systems’s stock is valued at $2.83 at 17:33 EST, way under its 52-week high of $5.42 and way higher than its 52-week low of $0.25.

Roadrunner Transportation Systems’s Moving Average

Roadrunner Transportation Systems’s worth is above its 50-day moving average of $2.65 and above its 200-day moving average of $2.61.

More news about Roadrunner Transportation Systems.

10. Marathon Oil (MRO) – -7.05%

Marathon Oil Corporation is an independent exploration company in Equatorial Guinea and the United States. It is involved in exploration, production and marketing crude oil, condensate and natural gas liquids; as well as the marketing and production of natural gas products such as methanol and liquefied natural gases. The company also owns 32 central gathering facilities, the Sugarloaf gathering network, a 42-mile natural gaz pipeline that runs through Karnes County and Atascosa Counties. It had proved developed reserves of 721 million barrels (mmboe) and 484 mmboe as of December 31, 2019. In July 2001, the company changed its name from USX Corporation to Marathon Oil Corporation. Marathon Oil Corporation was established in 1887. It is located in Houston, Texas.

NYSE ended the session with Marathon Oil sliding 7.05% to $23.14 on Wednesday while NYSE fell 0.43% to $14,352.78.

Volume

Today’s last reported volume for Marathon Oil is 21153200 which is 0.17% above its average volume of 21116200.

Marathon Oil’s last close was $24.90, 25.09% below its 52-week high of $33.24.

Marathon Oil’s Sales

Marathon Oil’s sales growth is 67.3% for the present quarter and 44% for the next. The company’s growth estimates for the current quarter and the next is 404.5% and 176.9%, respectively.

Marathon Oil’s Revenue

Year-on-year quarterly revenue growth grew by 109.1%, now sitting on 5.62B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Marathon Oil’s stock is considered to be overbought (>=80).

Marathon Oil’s Stock Yearly Top and Bottom Value

Marathon Oil’s stock is valued at $23.14 at 17:33 EST, way below its 52-week high of $33.24 and way above its 52-week low of $10.41.

Marathon Oil’s Moving Average

Marathon Oil’s value is way below its 50-day moving average of $27.46 and way higher than its 200-day moving average of $20.39.

More news about Marathon Oil.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here